基于新版GSP标准的医药冷链物流配送优化

展开
  • 上海大学管理学院, 上海 200444
于丽英(1969—), 女, 教授, 博士生导师, 博士, 研究方向为系统科学与战略创新、管理科学. E-mail: yuliying@shu.edu.cn

收稿日期: 2015-12-31

  网络出版日期: 2017-10-30

Optimization of distribution system for pharmaceutical cold-chain logistics based on new GSP standard

Expand
  • School of Management, Shanghai University, Shanghai 200444, China

Received date: 2015-12-31

  Online published: 2017-10-30

摘要

随着我国医药行业、物流行业的不断发展, 医药冷链物流市场发展潜力巨大. 分析了国内外医药冷链物流管理标准, 以新版产品供应规范(good supply practice, GSP)标准为基础, 总结了医药冷链物流配送问题的关注点, 并建立了医药冷链物流配送优化模型. 该模型以配送成本最小为目标, 在约束条件中考虑了供需平衡、中转站容量以及不同周期的最大运输量等问题. 以实例说明了改进后的配送方案符合新版GSP标准的要求且成本更低, 为构建高效率、低成本和低损耗率的医药冷链物流体系提供了一定的参考依据.

本文引用格式

熊永婧, 于丽英 . 基于新版GSP标准的医药冷链物流配送优化[J]. 上海大学学报(自然科学版), 2017 , 23(5) : 801 -809 . DOI: 10.12066/j.issn.1007-2861.1766

Abstract

With advances of pharmaceutical and logistics industries, the pharmaceutical cold-chain logistics market has great potential for development. This paper analyzes the progress and criterion, focuses on the distribution of pharmaceutical cold-chain logistics, and builds an optimization model for it. The model uses minimum distribution cost as an objective function with constraints such as co-ordination of supply and demand, capacity of transfer stations, and largest volume of different transportation cycles. An example is used to show that the improved method meets the demand of the new good supply practice(GSP) standard at a lower distribution cost. This work provides ideas for building a system of pharmaceutical cold-chain logistics with high-efficiency, low-cost and low attrition rate.

参考文献

[1] Kendal A P, Snyder R, Garrison P J. Validation of cold chain procedures suitable for distribution of vaccines by public health programs in the USA [J]. Vaccine, 1997, 15(12): 1459-1465.
[2] Chatterjee S, Pandey K G. Thermoelectric cold-chain chests for storing/transporting vaccines in remote regions [J]. Applied Energy, 2003, 76(4): 415-433.
[3] Parraga L P, G´omez-Lob´on A, Runnenberg I G, et al. Thermolabile drugs. operating procedure in the event of cold chain failure [J]. Farmacia Hospitalaria, 2011, 35(4): 190.e1-190.e28.
[4] van Arnum P. Expanding capabilities in the pharmaceutical cold chain [J]. Pharmaceutical Technology, 2012, 36(2): 42; 44-45.
[5] Muller R. 081 Ambient temperature stabilization of nucleic acids in human blood [J]. Cryobiology, 2013, 67(3): 420-421.
[6] Forcinio H. Packaging addresses cold-chain, requirements [J]. Pharmaceutical Technology, 2014, 38(10): 78-82.
[7] Thakur M, Foras E. EPCIS based online temperature monitoring and traceability in a cold meat chain [J]. Computers and Electronics in Agriculture, 2015, 117: 22-30.
[8] 杨冰芝, 蔡咏蓓. 浅谈医药行业物流配送的问题与对策[J]. 物流科技, 2009, 32(3): 45-48.
[9] 张维. 冷链物流在医药方面的应用[J]. 商场现代化, 2011(15): 49-51.
[10] 雍佳松, 杨世民. 我国医药冷链体系的现状及其发展建议[J]. 中国药房, 2014(25): 2308-2311.
[11] 赵贤. 中美药品冷链物流体系的比较研究[J]. 中国药业, 2012, 21(16): 15-16.
[12] 陈宁. 国外现代医药冷链物流模式对我国的启示[J]. 物流技术, 2014(11): 37-39.
[13] 王光明. 基于DEA的全国医药物流模式效率分析[J]. 时代金融, 2015, 35(12): 258-259.
[14] 冯健. 我国冷链物流政策演变与展望[J]. 物流工程与管理, 2015(11): 9-11.
[15] 牛秀明. “互联网+”下的医药物流发展[J]. 物流技术, 2015, 34(22): 31-34.

文章导航

/